Skip to main content
SpringerLink
Log in

Diabetes

  • Chapter
Book cover Cachexia and Wasting: A Modern Approach

  • 2126 Accesses

Abstract

Energy is constantly required in human life, whereas it is supplied only by intermittent food intake. Therefore, food is usually ingested in excess of the immediate caloric needs, and the extra calories are stored in the form of hepatic and muscle glycogen, adipose tissue triglycerides, and to a certain extent as muscle protein. In turn, these fuel reservoirs are broken down during starvation to provide energy for the body. The amount of glycogen stored in skeletal muscle is about 400 g (1600 Kcal), the amount of glycogen in liver is about 75 g (300 Kcal), and the amount of triglycérides stored in adipose tissue is about 15 000 g (141 000 Kcal), at overnight fasting state in healthy men.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chipkin SR, Kelly KL, Ruderman NB (1994) Hormone-fuel interrelationships: fed state, starvation, and diabetes mellitus. In: Kahn CR, Weir GC (ed) Joslin’s Diabetes Mellitus 13th ed. Lea & Febiger, Malvern, Pennsylvania, pp 97–115

    Google Scholar 

  2. Petersen KF, Laurent D, Rothman DL et al (1998) Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans. J Clin Invest 101:1203–1209

    PubMed  CAS  Google Scholar 

  3. Liu Z, Gardner LB, Barrett EJ (1993) Insulin and glucose suppress hepatic glycogenolysis by distinct enzymatic mechanisms. Metabolism 42:1546–1551

    Article  PubMed  CAS  Google Scholar 

  4. Bonadonna RC, Groop LC, Zych K et al (1990) Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. Am J Physiol 259:E736–E750

    PubMed  CAS  Google Scholar 

  5. Alberti KGMM, Zimmet PZ for the WHO Consultation (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. DiabetMed 15:539–553

    Google Scholar 

  6. Defronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194

    Article  PubMed  CAS  Google Scholar 

  7. Nair KS, Halliday D, Garrow JS (1984) Increased energy expenditure in poorly controlled type 1 (insulin-dependent) diabetic patients. Diabetologia 27:13–16

    Article  PubMed  CAS  Google Scholar 

  8. Bogardus C, Taskinen MR, Zawadzki J et al (1986) Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes 35:1–5

    Article  PubMed  CAS  Google Scholar 

  9. Fontvieille AM, Lillioja S, Ferraro RT et al (1992) Twenty-four-hour energy expenditure in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:753–759

    PubMed  CAS  Google Scholar 

  10. De Fronzo RA (1988) The triumvirate: α-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667–683

    Google Scholar 

  11. Consoli A, Nurjhan N, Capani F, Gerich J (1989) Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38:550–557

    Article  PubMed  CAS  Google Scholar 

  12. Ruderman NC, Toews JD, Shafrir E (1969) Role of free fatty acids in glucose homeostasis. Arch Intern Med 123:299–313

    Article  PubMed  CAS  Google Scholar 

  13. Ravussin E, Bogardus C, Schwartz RS et al (1983) Thermic effect of glucose and insulin infusion in man. J Clin Invest 72:893–902

    PubMed  CAS  Google Scholar 

  14. Franssila-Kallunki A, Groop L (1992) Factors associated with basal metabolic rate in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:962–966

    Article  PubMed  CAS  Google Scholar 

  15. Liu Z, Long W, Hillier T et al (1999) Insulin regulation of protein metabolism in vivo. Diab Nutr Metab 12:420–428

    CAS  Google Scholar 

  16. Jefferson LS (1980) Role of insulin in the regulation of protein synthesis. Diabetes 29:487–496

    PubMed  CAS  Google Scholar 

  17. Rodriguez T, Alvarez B, Busquets S et al (1997) The increased skeletal muscle protein turnover of the streptozotocin diabetic rat is associated with high concentrations of branched-chain amino acids. Biochem Mol Med 61:87–94

    Article  PubMed  CAS  Google Scholar 

  18. Robert JJ, Beaufrere B, Koziet J (1985) Whole-body de novo amino acid synthesis in type 1 (insulin-dependent) diabetes studied with stable isotope labelled leucine, alanine, and glycine. Diabetes 34:67–73

    Article  PubMed  CAS  Google Scholar 

  19. Nair KS, Garrow JS, Ford C et al (1983) Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 25:400–403

    Article  PubMed  CAS  Google Scholar 

  20. Umpleby AM, Boroujerdi MA, Brown PM et al (1986) The effect of metabolic control on leucine metabolism in type 1 (insulin-dependent) diabetic patients. Diabetologia 29:131–141

    Article  PubMed  CAS  Google Scholar 

  21. Luzi L, Castellino P, Simonson DC et al (1990) Leucine metabolism in IDDM. Role of insulin and substrate availability. Diabetes 39:38–48

    Article  PubMed  CAS  Google Scholar 

  22. Tessari P, Pehling G, Nissen SL et al (1988) Regulation of whole-body leucine metabolism with insulin during mixed meal absorption in normal and diabetic humans. Diabetes 37:512–519

    Article  PubMed  CAS  Google Scholar 

  23. Pacy PJ, Nair KS, Ford C, Halliday D (1989) Failure of insulin infusion to stimulate fractional muscle protein synthesis in type 1 diabetic patients. Diabetes 38:618–624

    Article  PubMed  CAS  Google Scholar 

  24. Bennet WM, Connacher AA, Smith K et al (1990) Inability to stimulate skeletal muscle or whole body protein synthesis in type 1 (insulin-dependent) diabetic patients by insulin-plus-glucose during amino acid infusion: studies of incorporation and turnover of tracer L-[1-13C] leucine. Diabetologia 33:43–51

    Article  PubMed  CAS  Google Scholar 

  25. Nair KS, Ford C, Ekberg K et al (1995) Protein dynamics in whole body and in splanchnic and leg tissues in type 1 diabetic patients. J Clin Invest 95:2926–2937

    PubMed  CAS  Google Scholar 

  26. De Feo P, Gan Gaisano M, Haymond MW (1991) Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest 88:833–840

    Article  PubMed  Google Scholar 

  27. De Feo P, Volpi E, Lucidi P et al (1993) Physiological increments in plasma insulin concentration have selective and different effects on synthesis of hepatic proteins in normal humans. Diabetes 42:995–1002

    Article  PubMed  Google Scholar 

  28. Luzi L, Petrides AS, DeFronzo RA (1993) Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM. Diabetes 42:1868–1877

    Article  PubMed  CAS  Google Scholar 

  29. Staten MA, Matthews DE, Bier DM (1986) Leucine metabolism in type II diabetes mellitus. Diabetes 35:1249–1253

    Article  PubMed  CAS  Google Scholar 

  30. Gougeon R, Pencharz PB, Marliss EB (1994) Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes 43:318–328

    Article  PubMed  CAS  Google Scholar 

  31. Gougeon R, Styhler K, Morais JA et al (2000) Effect of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care 23:1–8

    Article  PubMed  CAS  Google Scholar 

  32. Hugh-Jones P (1955) Diabetes in Jamaica. Lancet 269:891–897

    Article  PubMed  CAS  Google Scholar 

  33. Yajnik CS, Shelgikar KM, Sahasrabudhe RA et al (1990) The spectrum of pancreatic exocrine and endocrine (beta-cell) function in tropical calcific pancreatitis. Diabetologia 33:417–421

    Article  PubMed  CAS  Google Scholar 

  34. Dube MP, Johnson DL, Currier JS, Leedom JM (1997) Protease inhibitor-associated hyperglycemia. Lancet 350:713–714

    Article  PubMed  CAS  Google Scholar 

  35. Garg A (2004) Acquired and inherited lipodystrophies. N Engl J Med 350:1220–1234

    Article  PubMed  CAS  Google Scholar 

  36. Oral EA, Simha V, Ruiz E, et al (2002) Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570–578

    Article  PubMed  CAS  Google Scholar 

  37. Petersen KF, Oral EA, Dufour S et al (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345–1350

    Article  PubMed  CAS  Google Scholar 

  38. Simha V, Szczepaniak LS, Wagner AJ et al (2003) Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care 26:30–35

    Article  PubMed  CAS  Google Scholar 

  39. Snape WJ Jr, Battle WM, Schwartz SS et al (1982) Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind controlled trial. Ann Intern Med 96:444–446

    PubMed  Google Scholar 

  40. Heer M, Muller-Duysing W, Benes I et al (1983) Diabetic gastroparesis: treatment with domperidone-a double-blind placebo-controlled trial. Digestion. 27:214–217

    Article  PubMed  CAS  Google Scholar 

  41. Horowitz M, Roberts AP (1990) Long-term efficacy of cisapride in diabetic gastroparesis. Am J Med 88:195–196

    Article  PubMed  CAS  Google Scholar 

  42. Itoh Z, Nakaya M, Suzuki T et al (1984) Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol 247:G688–G694

    PubMed  CAS  Google Scholar 

  43. Okano H, Inui A, Ueno N et al (1996) EM523L, a nonpeptide motilin agonist, stimulates gastric emptying and pancreatic polypeptide secretion. Peptide 17:895–900

    Article  CAS  Google Scholar 

  44. Ogbonnaya KI, Arem R (1990) Diabetic diarrhea. Arch Intern Med 150:262–267

    Article  PubMed  CAS  Google Scholar 

  45. Ellenberg M (1974) Diabetic neuropathic cachexia. Diabetes 23:418–423

    PubMed  CAS  Google Scholar 

  46. Archer AG, Watkins PJ, Thomas PK et al (1983) The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 46:491–499

    PubMed  CAS  Google Scholar 

  47. Blau RH (1983) Diabetic neuropathic cachexia. Report of a women with this syndrome and review of the literature. Arch Intern Med 143:2011–2012

    Article  PubMed  CAS  Google Scholar 

  48. Godil A, Berriman D, Knapik S et al (1996) Diabetic neuropathic cachexia. West J Med 165:382–385

    PubMed  CAS  Google Scholar 

  49. Weintrob N, Josefsberg Z, Galazer A et al (1997) Acute painful neuropathic cachexia in a young type 1 diabetic woman. Diabetes Care 20:290–291

    PubMed  CAS  Google Scholar 

  50. Yuen KCJ, Day JL, Flannagan DW, Rayman G (2001) Diabetic neuropathic cachexia and acute bilateral cataract formation following rapid glycaemic control in a newly diagnosed type 1 diabetic patient. DiabetMed 18:854–857

    CAS  Google Scholar 

  51. Jackson CE, Barohn RJ (1998) Diabetic neuropathic cachexia: report of a recurrent case. J Neurol Neurosurg Psych 64:785–787

    CAS  Google Scholar 

  52. Gade GN, Hofeldt FD, Treece GL (1980) Diabetic neuropathic cachexia. Benefical response to combination therapy with amitriptyline and fluphenazine. JAMA 243:1160–1161

    Article  PubMed  CAS  Google Scholar 

  53. D’Costa DF, Price DE, Burden AC (1992) Diabetic neuropathic cachexia associated with malabsorption. Diabet Med 9:203–205

    Article  CAS  Google Scholar 

  54. Van Heel DA, Levitt NS, Winter TA (1998) Diabetic neuropathic cachexia: the importance of positive recognition and early nutritional support. Int J Clin Pract 52:591–592

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Molecular Medicine,Division of Diabetes and Digestive and Kidney Diseases, Kobe University Graduate School of Medicine, Kobe, Japan

    Takeshi Ohara

Authors
  1. Takeshi Ohara
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Oncology, University of Cagliari, Cagliari, Italy

    Giovanni Mantovani

  2. Department of Clinical Cardiology, Imperial College, NHLI, London, UK

    Stefan D. Anker

  3. Department of Cardiology Charité, Applied Cachexia Research, Campus Virchow-Klinikum, Berlin, Germany

    Stefan D. Anker

  4. Department of Behavioral Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

    Akio Inui

  5. GRECC, VA Medical Center and Division of Geriatric Medicine, Saint Louis University, St. Louis, MO, USA

    John E. Morley

  6. Department of Clinical Medicine, University of Rome, La Sapienza, Rome, Italy

    Filippo Rossi Fanelli

  7. Department of Infectious Diseases, IRCCS S.Matteo Polyclinic, University of Pavia, Pavia, Italy

    Daniele Scevola

  8. Bone Marrow and Blood Stem Cell Transplantation Program, Center for Lymphoma and Myeloma, New York Presbyterian Hospital/Weill Medical Center, New York, NY, USA

    Michael W. Schuster

  9. Department of Medicine-Geriatrics, University of New York at Stony Brook VAMC, Northport, NY, USA

    Shing-Shing Yeh

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Italia

About this chapter

Cite this chapter

Ohara, T. (2006). Diabetes. In: Mantovani, G., et al. Cachexia and Wasting: A Modern Approach. Springer, Milano. https://doi.org/10.1007/978-88-470-0552-5_28

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-0552-5_28

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-0471-9

  • Online ISBN: 978-88-470-0552-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation